Determining half-life of SARS-CoV-2 antigen in respiratory secretion

被引:3
|
作者
Guang, Yang [1 ]
Hui, Liu [1 ]
机构
[1] Dalian Med Univ, Dept Lab & Quarantine, Dalian, Peoples R China
关键词
SARS-CoV-2; COVID-19; Half-life; Environmental hygiene; CORONAVIRUS;
D O I
10.1007/s11356-023-27326-1
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is primarily transmitted from person to person through respiratory droplets and aerosols. It is also possible for the virus to be transmitted indirectly through environmental contamination. The likelihood of environmental transmission depends on several factors, including the survival time of the virus in respiratory secretions. However, the stability of SARS-CoV-2 in respiratory secretions has not been investigated. In this study, we compared the half-life of the SARS-CoV-2 antigen in respiratory secretion under different conditions. We applied respiratory secretion (5 mu L) to glass slides, air-dried the slides for 1 h, and kept them at 24 degrees C or 4 degrees C for 10 days. Respiratory secretions were also placed in test tubes (sealed to preserve moisture) and in normal saline for 10 days. The concentration of SARS-CoV-2 antigen in all samples was simultaneously measured using colloidal gold immunochromatography, and the half-life of the antigen was calculated. The half-life of the antigen in the wet (sealed tube) and saline samples at room temperature was 5.0 and 2.92 days, respectively. The half-life of the antigen in the air-dried sample at room temperature and at 4 degrees C was 2.93 and 11.4 days, respectively. The half-life was longer in respiratory secretions than that in normal saline. The half-life was also longer in respiratory secretions, at a lower temperature, and under wet conditions. Therefore, environmental transmission can also play a significant role in the spread of the virus. Robust prevention and control strategies could be developed based on the half-life of the antigen in respiratory secretions.
引用
收藏
页码:69697 / 69702
页数:6
相关论文
共 50 条
  • [21] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Feng, Wei
    Zong, Wei
    Wang, Feng
    Ju, Shaoqing
    MOLECULAR CANCER, 2020, 19 (01)
  • [22] The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2
    Li, Wendy
    Ma, Zhanshan
    MICROBIAL ECOLOGY, 2023, 86 (02) : 1428 - 1437
  • [23] Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit
    Kruettgen, Alexander
    Cornelissen, Christian G.
    Dreher, Michael
    Hornef, Mathias W.
    Imoehl, Matthias
    Kleines, Michael
    JOURNAL OF VIROLOGICAL METHODS, 2021, 288
  • [24] Usefulness of SARS-CoV-2 antigen test sample as input for SARS-CoV-2 RT-PCR analysis
    Garcia-Salguero, Cristina
    Culebras, Esther
    Merino, Paloma
    Baos, Elvira
    Delgado-Iribarren, Alberto
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1693 - 1695
  • [25] Superantigens and SARS-CoV-2
    Hamdy, Adam
    Leonardi, Anthony
    PATHOGENS, 2022, 11 (04):
  • [26] Profile of SARS-CoV-2
    Franz X. Heinz
    Karin Stiasny
    Wiener klinische Wochenschrift, 2020, 132 : 635 - 644
  • [27] Profile of SARS-CoV-2
    Heinz, Franz X.
    Stiasny, Karin
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (21-22) : 635 - 644
  • [28] SARS-CoV-2 and hypertension
    Ravichandran, Briyanth
    Grimm, Daniela
    Krueger, Marcus
    Kopp, Sascha
    Infanger, Manfred
    Wehland, Markus
    PHYSIOLOGICAL REPORTS, 2021, 9 (11):
  • [29] The heart and SARS-CoV-2
    Gonzalez-Calle, David
    Eiros, Rocio
    Sanchez, Pedro L.
    MEDICINA CLINICA, 2022, 159 (09): : 440 - 446
  • [30] SARS-CoV-2 Virology
    Li, Yijia
    Li, Jonathan Z.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (02) : 251 - 265